Alvotech (ALVO) Free Cash Flow (2021 - 2026)
Alvotech's (ALVO) quarterly Free Cash Flow came in at -$18.1 million in Q1 2026, down 144.62% YoY from $40.6 million in Q1 2025, and down 166.45% on a QoQ basis from $27.2 million in Q4 2025.
Alvotech (ALVO) Free Cash Flow (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Free Cash Flow data on file, last reported at -$18.1 million in Q1 2026.
- Quarterly Free Cash Flow fell 144.62% year-over-year to -$18.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$173.3 million (up 29.2% YoY) and the FY2025 annual result came in at -$114.7 million, up 60.53% from the prior year.
- Free Cash Flow retreated to -$18.1 million in Q1 2026, from $27.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $64.5 million in Q2 2025 to a low of -$279.0 million in Q4 2023.
- A 5-year average of -$86.0 million and a median of -$57.8 million in 2024 frame the typical range for Free Cash Flow.
- The widest YoY moves for Free Cash Flow: up 245.34% in 2025, down 327.19% in 2025.
- Tracing ALVO's Free Cash Flow over 5 years: stood at -$274.5 million in 2022, then declined by 1.62% to -$279.0 million in 2023, then soared by 34.33% to -$183.2 million in 2024, then surged by 114.87% to $27.2 million in 2025, then plunged by 166.45% to -$18.1 million in 2026.
- The last three Free Cash Flow figures came in at -$18.1 million (Q1 2026), $27.2 million (Q4 2025), and -$247.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alvotech | 1.30 Bn | 1.30 Bn | 5.09 Mn | -53.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.10 Mn |
| Mar 31, 2026 | -18.10 Mn |
| Dec 31, 2025 | 27.24 Mn |
| Dec 31, 2025 | 27.24 Mn |
| Sep 30, 2025 | -247.01 Mn |
| Sep 30, 2025 | -247.01 Mn |
| Jun 30, 2025 | 64.52 Mn |
| Jun 30, 2025 | 64.52 Mn |
| Mar 31, 2025 | 40.57 Mn |
| Mar 31, 2025 | 40.57 Mn |
| Dec 31, 2024 | -183.18 Mn |
| Dec 31, 2024 | -183.18 Mn |
| Sep 30, 2024 | -57.82 Mn |
| Sep 30, 2024 | -57.82 Mn |
| Jun 30, 2024 | -44.40 Mn |
| Jun 30, 2024 | -44.40 Mn |
| Mar 31, 2024 | -71.33 Mn |
| Mar 31, 2024 | -71.33 Mn |
| Dec 31, 2023 | -278.95 Mn |
| Dec 31, 2023 | -278.95 Mn |